Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 1375 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 11
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 134
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1561
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 159
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Aiguo, Lu | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aiguo, Lu.temp.org | 2025-07-14 |
| Aijun Sun | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aijun Sun.temp.org | 2025-07-14 |
| Aikaterini Thanou | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aikaterini Thanou.temp.org | 2025-07-14 |
| Aileen Bergström | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aileen Bergström.temp.org | 2025-07-14 |
| Aileen Davis | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aileen Davis.temp.org | 2025-07-14 |
| Aileens Pharma SRL | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aileens Pharma SRL.temp.org | 2025-07-14 |
| Aileron Therapeutics, Inc. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Aileron Therapeutics, Inc..temp.org | 2025-07-14 |
| Ailin Luo | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Ailin Luo.temp.org | 2025-07-14 |
| Aiman Al-Touny | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aiman Al-Touny.temp.org | 2025-07-14 |
| Aimee Li | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aimee Li.temp.org | 2025-07-14 |
| Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aimei Vacin BioPharm (Zhejiang) Co., Ltd..temp.org | 2025-07-14 |
| Aimen F. Shaaban, MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aimen F. Shaaban, MD.temp.org | 2025-07-14 |
| Aimin Dang | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aimin Dang.temp.org | 2025-07-14 |
| Aimin Zhao | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aimin Zhao.temp.org | 2025-07-14 |
| Aimmune Therapeutics, Inc. | - | 11 | 0.0% | 0 | 0 | 0.0% | - | Aimmune Therapeutics, Inc..temp.org | 2025-07-14 |
| Ain Shams Maternity Hospital | - | 134 | 0.0% | 0 | 0 | 0.0% | - | Ain Shams Maternity Hospital.temp.org | 2025-07-14 |
| Ain Shams University | - | 1561 | 0.0% | 0 | 0 | 0.0% | - | Ain Shams University.temp.org | 2025-07-14 |
| Aina Chalabaev | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aina Chalabaev.temp.org | 2025-07-14 |
| Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Ainos, Inc. (f/k/a Amarillo Biosciences Inc..temp.org | 2025-07-14 |
| Ainsworth Institute of Pain Management | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ainsworth Institute of Pain Management.temp.org | 2025-07-14 |
| Aionx, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aionx, Inc..temp.org | 2025-07-14 |
| Aiping Shi | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aiping Shi.temp.org | 2025-07-14 |
| Aiping Zhou | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Aiping Zhou.temp.org | 2025-07-14 |
| Air Force Military Medical University, China | - | 159 | 0.0% | 0 | 0 | 0.0% | - | Air Force Military Medical University, China.temp.org | 2025-07-14 |
| Air Force Specialized Hospital, Cairo, Egypt | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Air Force Specialized Hospital, Cairo, Egypt.temp.org | 2025-07-14 |